top of page
36 Months to Market Readiness
Work Packages
01-04
Formulation Optimization
Engineering the molecular architecture of OssiGel to ensure optimal mechanical strength and biocompatibility for bone repair.
05-08
Preclinical Efficacy
Large-animal studies to validate the regenerative capacity of OssiGel in complex bone defect models and assess long-term stability.
09-12
GLP Safety Studies
Rigorous toxicological evaluation in compliance with GLP standards to ensure the safety and absence of adverse effects in humans.
13-16
Clinical Trial Prep
Preparing for Phase I clinical trials through detailed protocol development, regulatory documentation, and manufacturing scalability.
17-24
Market Readiness
Finalizing commercialization pathways, investor readiness, and market entry strategies to ensure global accessibility of OssiGel.
Paving the Way for Clinical Trials
bottom of page